BlackRock’s Decoy Therapeutics DCOY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Hold |
0
| – | -$1 | – | 5587 |
|
|
2025
Q2 | – | Hold |
0
| – | – | – | 5455 |
|
|
2025
Q1 | – | Hold |
0
| – | – | – | 5426 |
|
|
2024
Q4 | – | Hold |
0
| – | – | – | 5385 |
|
|
2024
Q3 | – | Hold |
0
| – | – | – | 5221 |
|
|
2024
Q2 | – | Hold |
0
| – | – | – | 5274 |
|
|
2024
Q1 | – | Hold |
0
| – | – | – | 5275 |
|
|
2023
Q4 | – | Hold |
0
| – | – | – | 5347 |
|
|
2023
Q3 | – | Hold |
0
| – | – | – | 5420 |
|
|
2023
Q2 | – | Hold |
0
| – | – | – | 5468 |
|
|
2023
Q1 | – | Hold |
0
| – | – | – | 5535 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 5728 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 5915 |
|
|
2022
Q2 | – | Sell |
-3
| Closed | -$25.9K | – | 5969 |
|
|
2022
Q1 | $45K | Hold |
3
| – | – | ﹤0.01% | 5433 |
|
|
2021
Q4 | $59K | Hold |
3
| – | – | ﹤0.01% | 5378 |
|
|
2021
Q3 | $119K | Sell |
3
-1
| -25% | -$34.5K | ﹤0.01% | 5098 |
|
|
2021
Q2 | $142K | Buy |
+4
| New | +$178K | ﹤0.01% | 4969 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 5210 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 5031 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 5010 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 4920 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 4924 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 4820 |
|
|
2019
Q3 | – | Hold |
0
| – | – | – | 4773 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 4715 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 4587 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 4596 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 4623 |
|
|
2018
Q2 | – | Hold |
0
| – | – | – | 4559 |
|
|
2018
Q1 | – | Hold |
0
| – | – | – | 4174 |
|
|
2017
Q4 | – | Hold |
0
| – | – | – | 4247 |
|
|
2017
Q3 | – | Hold |
0
| – | – | – | 4280 |
|
|
2017
Q2 | – | Sell |
-1
| Closed | -$3.26M | – | 4257 |
|
|
2017
Q1 | $2.05M | Buy |
+1
| New | +$4.08M | ﹤0.01% | 3646 |
|
|
2016
Q4 | – | Hold |
0
| – | – | – | 3648 |
|
|
2016
Q3 | – | Hold |
0
| – | – | – | 3481 |
|
|
2016
Q2 | – | Hold |
0
| – | – | – | 3519 |
|
|
2016
Q1 | – | Hold |
0
| – | – | – | 3555 |
|
Other funds holding DCOY
ASN
DB
BlackRock's DCOY Position: Q3 2025 in Review
BlackRock held its Decoy Therapeutics (DCOY) position steady in Q3 2025 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #5587.
BlackRock first reported a position in DCOY in Q1 2017 and has held it in 5 quarters since. The position peaked at $2.05M in Q1 2017. 3 funds tracked by Wall St. Rank hold DCOY as of Q3 2025.
- BlackRock held 0 shares of Decoy Therapeutics worth $0 as of Q3 2025.
- BlackRock left its Decoy Therapeutics share count unchanged in Q3 2025.
- Decoy Therapeutics made up ﹤0.01% of BlackRock's portfolio in Q3 2025, its #5587 holding.
- BlackRock first reported a position in Decoy Therapeutics in Q1 2017 and has held it in 5 quarters since.
- BlackRock's Decoy Therapeutics position peaked at $2.05M in Q1 2017.
- 3 funds tracked by Wall St. Rank held Decoy Therapeutics as of Q3 2025.
Based on BlackRock's 13F filing for Q3 2025, filed 12 Nov 2025.